Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
Cashman
J D
JD
Terry Fox Laboratory, B.C. Cancer Agency, Vancouver, Canada.
Eaves
A C
AC
Wolpe
S
S
Eaves
C J
CJ
D001853:Bone Marrow / Q000187:drug effects / Q000502:physiology*; D001854:Bone Marrow Cells; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D054407:Chemokine CCL4; D003114:Colony-Forming Units Assay; D016207:Cytokines / Q000494:pharmacology / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D019402:Macrophage Inflammatory Proteins; D015846:Monokines / Q000494:pharmacology / Q000502:physiology*; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000473:pathology / Q000502:physiology; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000473:pathology / Q000502:physiology; D014410:Tumor Stem Cell Assay
D054407:Chemokine CCL4; D016207:Cytokines; D019402:Macrophage Inflammatory Proteins; D015846:Monokines